EUVIMEDSkopri EUVIMED
Open access · CC BY-NC-ND 4.0

The optimal blood pressure target in old and very old patients with hypertension

Ran Zhang iD, Ivan Chun Hang Lam iD, Xinyi Liu iD, Feng Sun iD, Siyan Zhan iD, Kai Hang Yiu iD, Celine Sze Ling Chui iD, Esther Wai Yin Chan iD, Ian Chi Kei Wong iD, Cindy Lo Kuen Lam iD, Eric Yuk Fai Wan iD

Age and Ageing · 2026-06-01 · 55 (6)

DOI: 10.1093/ageing/afag167 ↗

At a glance

Journal article in Age and Ageing, published online on 2026-06-08. Written by Ran Zhang and 10 co-authors. Institution: Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, No. 21 Sas…. Major MEDLINE topics: Hypertension, Antihypertensive Agents, Blood Pressure. Cited 1 times so far (Crossref); 22 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

With the rise in older population globally, the optimal blood pressure (BP) target for antihypertensive therapy in those aged 60 and above remains to be evaluated in the real-world practice. This study evaluated the effectiveness and safety of standard versus lower BP targets in old (aged 60–79) and very old (aged ≥80) patients with hypertension in real-world clinical settings.

Methods

We emulated a target trial using electronic medical records from the Hong Kong Hospital Authority, including patients aged 60 years or above with a diagnosis of hypertension, uncontrolled BP and records of antihypertensives adjustments from 2008 to 2013. Patients were first categorized into 3 age groups (60–69, 70–79, ≥ 80) and then assigned to BP targets of either 130–140/80–90 mmHg or below 130/80 mmHg. Outcomes included major cardiovascular disease (CVD), end-stage renal disease, all-cause mortality and major adverse events related to antihypertensive treatment.

Results

Of 132 430 eligible patients identified, 52 553, 28 661 and 7106 patients aged 60–69, 70–79 and ≥ 80 years had BP targets of 130–140/80–90 mmHg, respectively; 11 148, 5636 and 1203 of patients in the same age groups had targets below 130/80 mmHg. Lower BP target was associated with reduced overall CVD and all-cause mortality: aged 60–69 years (CVD HR: 0.91 [95% CI, 0.85–0.96]; all-cause mortality: 0.89 [0.81–0.98]), aged 70–79 years (CVD: 0.87 [0.82–0.93]; all-cause mortality: 0.84 [0.78–0.91]), and aged≥80 years (CVD: 0.77 [0.69–0.86]; all-cause mortality: 0.80 [0.72–0.89]). No significant increase in major adverse events was observed in any age group. Results were consistent across all subgroups.

Conclusion

Lowering BP of below 130/80 mmHg in old and very old patients was associated with better cardiovascular and mortality outcomes without increased adverse events. These findings suggest that a lower BP target may be beneficial and safe for older patients with hypertension.

Subjects

MeSH terms (MEDLINE)

HypertensionAntihypertensive AgentsBlood PressureHumansFemaleAgedMaleAged, 80 and overAge FactorsMiddle AgedTreatment OutcomeHong KongRisk FactorsTime FactorsElectronic Health RecordsCardiovascular Diseases

Author keywords

antihypertension managementblood pressurehypertensionolder patients

Substances

Antihypertensive Agents

Authors and institutions

  • Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, No. 21 Sassoon Road, Pokfulam, Hong Kong Special Administrative Region, China.
  • Pharmaco- and Device Epidemiology, Health Data Sciences, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, United Kingdom.
  • Department of Epidemiology and Biostatistics, School of Public Health, Peking University, No. 38 Xueyuan Road, Haidian District, Beijing 100191, China.
  • Key Laboratory of Epidemiology of Major Diseases, Ministry of Education, Peking University, No. 38 Xueyuan Road, Haidian District, Beijing 100191, China.
  • Cardiology Division, Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, No. 102 Pokfuam Road, Pokfulam, Hong Kong Special Administrati…
  • Cardiology Division, Department of Medicine, The University of Hong Kong-Shenzhen Hospital, No. 1 Haiyuan First Road, Futian District, Shenzhen, China.

ORCID profiles: Ran Zhang, Ivan Chun Hang Lam, Xinyi Liu, Feng Sun, Siyan Zhan, Kai Hang Yiu, Celine Sze Ling Chui, Esther Wai Yin Chan, Ian Chi Kei Wong, Cindy Lo Kuen Lam, Eric Yuk Fai Wan

Cite

APA

Zhang, R., Lam, I. C. H., Liu, X., Sun, F., Zhan, S., Yiu, K. H., Chui, C. S. L., Chan, E. W. Y., Wong, I. C. K., Lam, C. L. K., & Wan, E. Y. F. (2026). The optimal blood pressure target in old and very old patients with hypertension. Age and Ageing, 55(6). https://doi.org/10.1093/ageing/afag167

Vancouver

Zhang R, Lam ICH, Liu X, Sun F, Zhan S, Yiu KH, et al. The optimal blood pressure target in old and very old patients with hypertension. Age and Ageing. 2026;55(6). doi:10.1093/ageing/afag167

BibTeX
@article{Zhang2026,
  author = {Zhang, Ran and Lam, Ivan Chun Hang and Liu, Xinyi and Sun, Feng and Zhan, Siyan and Yiu, Kai Hang and Chui, Celine Sze Ling and Chan, Esther Wai Yin and Wong, Ian Chi Kei and Lam, Cindy Lo Kuen and Wan, Eric Yuk Fai},
  title = {The optimal blood pressure target in old and very old patients with hypertension},
  journal = {Age and Ageing},
  year = {2026},
  volume = {55},
  number = {6},
  doi = {10.1093/ageing/afag167}
}
Start for free →